J&J, GE team up to create Alzheimer's disease diagnostic
Executive Summary
General Electric Co.'s GE Healthcare and Johnson & Johnson's Janssen Pharmaceutica NV will team up to discover a biomarker for Alzheimer's disease.
Deal Industry
- In Vitro Diagnostics
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice